Nivestym
NDC 0069-0293, filgrastim-aafi, injection, solution, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-0293
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761080
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0293 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FILGRASTIM300 ug/mL
Pharmacologic classes
Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-0293-10 | 00069029310 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0069-0293-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-0293-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d23ab39c-b6ec-41cf-a529-9dd2852c9d9aMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0069-0293
Use it
Look up 0069-0293 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0293 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-0293. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.